We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CBOE:CBOECboe Global Markets, Inc. Analysis

Data as of 2026-08-24 - not real-time

$300.74

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Cboe Global Markets, Inc. is neutral at $300.74, with no clear ordering between short and long averages. It has gained 12.2% over the past 30 days. With RSI at 57.9 the momentum picture is neutral, alongside a bearish MACD signal. Watch $273.36 as support and $311.06 as the nearer resistance level.
The shares look overvalued, trading on 23.4 times earnings above a sector average of 16.8. Sell-side targets cluster 4.8% above the current quote. Revenue is growing at 22.9% on a 26.7% profit margin. The 1.14% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 37.8%, a beta of -0.35 and a maximum drawdown of 36.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Updated Jul 31, 2026 0 Second Quarter Highlights\ - Diluted EPS for the Quarter of $3.Updated Aug 6, 2026 0 - Service expected to launch on August 24, covering EU, Swiss, UK and U.Cboe Global Markets, Inc. NASDAQ:CBOE is one of the 15 Set-It-and-Forget-It Stocks to Buy in 2026. On March 9, 2026,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 282.85
  • MACD momentum is negative
  • 30-day price change of +12.2%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 23.4 versus sector average of 16.8
  • Trading above the 200-day average of 282.85
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 23.4 versus sector average of 16.8
  • Profit margin of 26.7% is healthy
  • Revenue growth of +22.9%

Key Metrics & Analysis

Financial Health

Revenue Growth22.90%
Profit Margin26.73%
P/E Ratio23.4
ROE26.30%
ROA11.58%
Debt/Equity28.09
P/B Ratio5.6
Op. Cash Flow$2.0B
Free Cash Flow$678.2M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI57.9
Support$273.36
Resistance$311.06
MA 20$292.86
MA 50$276.41
MA 200$282.85
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41

Valuation

Fair Value$217.17
Target Price$315.14
Upside/Downside4.79%
GradeOvervalued
TypeGrowth
Dividend Yield1.14%

Risk Assessment

Beta-0.35
Volatility37.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.